Fiche société
University of Pisa
Traitements, essais et publications liés.
Traitements2programmes
Essais1liés
Publications2liées
SourceDBlocale
Traitements
2| Molécule | Indication / population | Phase | Objectif | Pays | Résultat |
|---|---|---|---|---|---|
| oral Prednisone 5mgThis is a 36 months, randomized, double-blind, placebo-controlled, parallel-groups, equivalence multicenter trial in patients with inactive Systemic Lupus Erythematosus to evaluate if low disease activity can be sustained with withdrawal of glucocorticoids in patients on stable clinical remission or low disease activity. | Lupus | NA | À vérifier | À vérifier | |
| oral Prednisone 5mgThis is a 36 months, randomized, double-blind, placebo-controlled, parallel-groups, equivalence multicenter trial in patients with inactive Systemic Lupus Erythematosus to evaluate if low disease activity can be sustained with withdrawal of glucocorticoids in patients on stable clinical remission or low disease activity. | Lupus | NA | À vérifier | À vérifier |
Essais cliniques
1| Molécule | Indication / population | Phase | NCT | Titre | Statut |
|---|---|---|---|---|---|
| oral Prednisone 5mg | Lupus | NA | NCT03804723 | Glucocorticoids Withdrawal in Early Systemic Lupus Erythematosus | UNKNOWN |
Publications
2| Molécule | Indication / population | Titre | Journal | Date |
|---|---|---|---|---|
| oral Prednisone 5mg | Effectiveness and safety of glucocorticoids bridging rituximab in neuromyelitis spectrum disorder. | Multiple sclerosis and related disorders | ||
| oral Prednisone 5mg | Real-World Effectiveness of Tezepelumab Across T2 and Non-T2 Severe Asthma Phenotypes: A Multicenter Spanish Cohort Study. | Archivos de bronconeumologia |